• Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10071072).
  

CLPUB00106
Wiemann M.C., Hollmann A., Posner M.R.
Establishment of a new Philadelphia chromosome-positive human chronic myeloid leukemia cell line.
Clin. Res. 33:460A-460A(1985)

PubMed=3332852; DOI=10.1016/S0950-3536(87)80037-9
Keating A.
Ph positive CML cell lines.
Baillieres Clin. Haematol. 1:1021-1029(1987)

PubMed=2159372
Lasky S.R., Bell W., Huhn R.D., Posner M.R., Wiemann M.C., Calabresi P., Eil C.
Effects of 1 alpha, 25-dihydroxyvitamin D3 on the human chronic myelogenous leukemia cell line RWLeu-4.
Cancer Res. 50:3087-3094(1990)

PubMed=1372318; DOI=10.1007/BF01410133
Clark J.W., Posner M.R., Marsella J.M., Santos A., Uskokovic M., Eil C., Lasky S.R.
Effects of analogs of 1,25(OH)2 vitamin D3 on the proliferation and differentiation of the human chronic myelogenous leukemia cell line, RWLeu-4.
J. Cancer Res. Clin. Oncol. 118:190-194(1992)

PubMed=7994044; DOI=10.1182/blood.V84.12.4283.bloodjournal84124283
Lasky S.R., Posner M.R., Iwata K., Santos-Moore A., Yen A., Samuel V., Clark J.W., Maizel A.L.
Characterization of a vitamin D3-resistant human chronic myelogenous leukemia cell line.
Blood 84:4283-4294(1994)

PubMed=8635507; DOI=10.1006/excr.1996.0165
Iwata K., Kouttab N., Ogata H., Morgan J.W., Maizel A.L., Lasky S.R.
Differential regulation of vitamin D receptors in clonal populations of a chronic myelogenous leukemia cell line.
Exp. Cell Res. 225:143-150(1996)

PubMed=10071072; DOI=10.1016/s0145-2126(98)00171-4
Drexler H.G., MacLeod R.A.F., Uphoff C.C.
Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
Leuk. Res. 23:207-215(1999)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001)